Veterinary Medicines

Furosoral 40 mg tablets for dogs and cats

Authorised
  • Furosemide
Download as PDF

Product identification

Medicine name:
Furosoral 40 mg tablets for dogs and cats
Furosoral 40 mg Tabletten für Katzen und Hunde
Active substance:
  • Furosemide
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Furosemide
    40.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC03CA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • Cardboard box of 5 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 100 Aluminium-PVDC/PVC blisters with 10 tablets each. Cardboard box containing 10 separate cardboard boxes, each containing 1 blister of 10 tablets
  • Cardboard box of 10 Aluminium-PVDC/PVC blisters with 10 tablets each. Cardboard box containing 10 separate cardboard boxes, each containing 1 blister of 10 tablets
  • Cardboard box of 2 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 25 Aluminium-PVDC/PVC blisters with 10 tablets each. Cardboard box containing 10 separate cardboard boxes, each containing 1 blister of 10 tablets
  • Cardboard box of 7 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 6 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 50 Aluminium-PVDC/PVC blisters with 10 tablets each. Cardboard box containing 10 separate cardboard boxes, each containing 1 blister of 10 tablets.
  • Cardboard box of 4 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 3 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 1 Aluminium-PVDC/PVC blister with 10 tablets
  • Cardboard box of 8 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 9 Aluminium-PVDC/PVC blisters with 10 tablets each

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Artesan Pharma GmbH & Co. KG
  • Lelypharma B.V.
  • Genera d.d.
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 402694.00.00
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0192/002
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 22/01/2024
Download
German (PDF)
Published on: 20/12/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."